Accession Number:

AD1040548

Title:

Annual Surveillance Summary: Acinetobacter Species Infections in the Military Health System (MHS), 2016

Descriptive Note:

Technical Report,01 Jan 2016,31 Dec 2016

Corporate Author:

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER PORTSMOUTH VA PORTSMOUTH United States

Personal Author(s):

Report Date:

2017-06-01

Pagination or Media Count:

21.0

Abstract:

The EpiData Center Department EDC conducts routine surveillance of Acinetobacter species incidence and prevalence among all beneficiaries seeking care within the Military Health System MHS. This report describes demographics, clinical characteristics, prescription practices, and antibiotic resistance patterns observed for Acinetobacter species infections in calendar year CY 2016. Several data sources were linked to assess a variety of descriptive and clinical factors related to Acinetobacter species infections. Health Level 7 HL7-formatted Composite Health Care System CHCS microbiology data identified Acinetobacter species infections. These infections were matched to HL7-formatted CHCS pharmacy data to assess prescription practices, the Standard Inpatient Data Record SIDR to determine healthcare-associated exposures, Defense Manpower Data Center DMDC rosters to determine burden among Department of Defense DOD active duty AD service members, and the DMDC Contingency Tracking System CTS to determine Department of the Navy DON deployment-related infections. In 2016, the Acinetobacter species incidence rate was 5.32 per 100,000 persons per year, which reflects a slight decrease from the weighted historic incidence rate. The majority of infections in 2016 were identified in the outpatient setting and manifested as wounds and skin and soft tissue infections SSTIs. Acinetobacter baumannii-calcoaceticus complex ABC was the most common species isolated 27.6 . Overall, incidence of drug-resistant Acinetobacter species remains low in the DOD 0.22 per 100,000 persons per year and antibiotic susceptibilities are high. Many antibiotics display statistically significant ascending trends in efficacy. Current infection control practices appear effective and continued surveillance is recommended.

Subject Categories:

  • Microbiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE